肠道微生物代谢物调控功能性便秘的靶点挖掘及作用机制研究Target mining and mechanism study of gut microbiota metabolites in regulating functional constipation
张慧娥,肖梦丽,程玉荣,郑爽,姜琳琳,陆芳
摘要(Abstract):
目的:探究肠道微生物代谢物调控功能性便秘(functional constipation, FC)的关键靶点与作用机制,为FC的靶向治疗提供理论依据。方法:依托多个生物信息数据库,分别获取肠道微生物代谢物靶点、FC疾病靶点,取交集得到共有靶点;利用R软件开展GO、KEGG富集分析,评估核心代谢物成药性与毒性,通过分子对接验证代谢物与靶点结合能力,最终构建微生物-底物-代谢物-靶点调控网络。结果:共筛选出34个FC与肠道微生物代谢物共有靶点;靶点主要富集于氧化应激、炎症反应相关生物学过程及AGE-RAGE、Toll样受体等信号通路;19种核心代谢物具备良好成药潜力,色胺、3-吲哚丙酸等核心代谢物可与关键靶点稳定结合;调控网络明确了5个核心致病靶点及对应的肠道微生物、代谢物调控链条。结论:肠道微生物代谢物可通过调控氧化应激、炎症反应及多条关键信号通路影响FC的发病,其调控机制与中医脾胃气机相关理论相符,可为FC靶向用药及中医药现代化研究提供参考。
关键词(KeyWords): 功能性便秘;肠道微生物;代谢物;网络药理学;中医
基金项目(Foundation): 中国中医科学院科技创新工程重大攻关项目(No:CI2026A04710);; 北京市研究型病房卓越临床研究计划(No:BRWEP2024Z014170102)
作者(Author): 张慧娥,肖梦丽,程玉荣,郑爽,姜琳琳,陆芳
参考文献(References):
- [1] 中国中西医结合学会消化系统疾病专业委员会.功能性便秘中西医结合诊疗专家共识(2025年)[J].中国中西医结合消化杂志,2025,33(3):195-216.
- [2] 马多多,张杨.功能性便秘的中医药研究进展[J].临床医学进展,2024,14(6):1171-1176.
- [3] 杨威,罗敏,鲁海燕.中医基于调中复衡理论探讨慢性便秘辨治新思路[J].中国现代医生,2025,63(11):81-84.
- [4] 荆新昆,朱兰,郑薇薇.从脾失健运论治功能性便秘[J].中国民间疗法,2025,33(8):7-11.
- [5] 陈格格,张涛,王欣,等.从“滞、郁、虚、瘀”论治功能性便秘[J].北京中医药,2022,41(4):361-364.
- [6] 康书芹,梁磊,王雷,等.基于“脾为之卫”理论辨证论治老年功能性便秘经验[J].中国医药导报,2025,22(18):164-167,183.
- [7] 蒲倩薇,万于,刘建平,等.功能性便秘发病机制的现代研究进展[J].中国肛肠病杂志,2024,44(11):68-72.
- [8] 何岳珍,陈静,史正刚,等.脾主运化理论与肠道微生态相关性研究[J].中医儿科杂志,2023,19(6):100-103.
- [9] Li LR,Li TX,Liang X,et al.A decrease in Flavonifractor plautii and its product,phytosphingosine,predisposes individuals with phlegm-dampness constitution to metabolic disorders[J].Cell Discov,2025,11:25.
- [10] de Vos WM,Tilg H,Van HM,et al.Gut microbiome and health:mechanistic insights[J].Gut,2022,71(5):1020-1032.
- [11] Hays KE,Pfaffinger JM,Ryznar R.The interplay between gut microbiota,short-chain fatty acids,and implications for host health and disease[J].Gut Microbes,2024,16(1):2393270.
- [12] 张红阳,邱志兵,陈坚.肠道菌群-宿主代谢轴与肠道疾病[J].上海医药,2024,45(19):7-11.
- [13] 王坪霏,许军峰,秦文秀,等.基于脑-肠轴探讨中药防治功能性便秘的作用机制[J].中医药临床杂志,2024,36(9):1833-1839.
- [14] Yao WG,Huo JL,Ji J,et al.Elucidating the role of gut microbiota metabolites in diabetes by employing network pharmacology[J].Mol Med,2024,30(1):263.
- [15] Yuan TY,Xing JY,Liu PT.Decoding the gut microbiota metabolite-matrix metalloproteinase-3 axis in breast cancer:a multi-omics and network pharmacology study[J].Mol Divers,2026,30(3):4059-4071.
- [16] 刘双,董红敬,张艳艳,等.中医药治疗便秘的用药规律及网络药理学探析[J].山东科学,2022,35(6):24-32.
- [17] 赵江峰,徐江林,何佳乐,等.基于数据挖掘、网络药理学及实验验证探究清毒稳心方治疗扩张型心肌病的用药规律及作用机制[J].中草药,2025,56(19):7118-7129.
- [18] Li TH,Jing HR,Gao XY,et al.Identification of key genes as diagnostic biomarkers for IBD using bioinformatics and machine learning[J].J Transl Med,2025,23(1):738.
- [19] Srinivasan M,Gangurde A,Chandane AY,et al.Integrating network pharmacology and in silico analysis deciphers With afer in-a's anti-breast cancer potential via hedgehog pathway and target network interplay[J].Brief Bioinform,2024,25(2):bbae032.
- [20] Gao JX,Yue MY,Huang JZ,et al.The HIF-1α signaling pathway:a key approach to revealing the effects of Scutellaria baicalensis Georgi against lipopolysaccharide-induced spontaneous abortion[J].Phytomedicine,2025,145:157013.
- [21] He Y,Sun MM,Zhang GG,et al.Targeting PI3K/Akt signal transduction for cancer therapy[J].Signal Transduct Target Ther,2021,6:425.
- [22] Chen L,Chang XB,Wu CT,et al.Polysaccharide extracted from Atractylodes macrocephala improves the spleen deficiency constipation in mice by regulating the gut microbiota to affect the 5-HT synthesis[J].Neurogastroenterol Motil,2024,36(10):e14875.
- [23] Florescu DN,Boldeanu MV,??erban RE,et al.Correlation of the pro-inflammatory cytokines IL-1β,IL-6,and TNF-α,inflammatory markers,and tumor markers with the diagnosis and prognosis of colorectal cancer[J].Life,2023,13(12):2261.
- [24] Zhang SF,Zhong RQ,Zhou M,et al.Mechanisms of baicalin alleviates intestinal inflammation:role of M1 macrophage polarization and Lactobacillus amylovorus[J].Adv Sci,2025,12(21):2415948.
- [25] Wang FM,Lu CP,Lei Y,et al.Prolonged humid heat triggers systemic inflammation and stress signaling:fluid intake modulates NF-κB,p38,JNK2,and STAT3α pathways[J].Int J Mol Sci,2025,26(11):5114.
- [26] Liu YQ,Su ZY,Tavana O,et al.Understanding the complexity of p53 in a new era of tumor suppression[J].Cancer Cell,2024,42(6):946-967.
- [27] 王金鑫,谢胜,黄茂光,等.肠紧密连接在溃疡性结肠炎中的作用及中药治疗进展[J].中国实验方剂学杂志,2023,29(15):249-255.
- [28] 慈小燕,孙英辉,武卫党,等.淫羊藿苷元的肠道跨膜转运机制研究[J].中草药,2022,53(9):2747-2755.
- [29] 张利,李佳莉,高苑,等.淫羊藿素的药理作用及机制研究进展[J].中草药,2024,55(17):6069-6077.
- [30] Agus A,Planchais J,Sokol H.Gut microbiota regulation of tryptophan metabolism in health and disease[J].Cell Host Microbe,2018,23(6):716-724.
- [31] 吴斌,王旭,付东旭,等.疏肝解郁方对便秘型肠易激综合征大鼠模型的疗效及脑-肠轴功能的影响[J].实验动物与比较医学,2022,42(6):551-559.
- [32] 朱万涌,王乐,徐越,等.肠道菌群失衡与功能性肠病:从机制探讨到肠菌移植疗法[J].中华结直肠疾病电子杂志,2025,14(2):142-147.
- [33] 庄羽骁,杨姗莹,龚彪,等.肠道微生态参与功能性便秘发生机制的研究进展[J].国际消化病杂志,2021,41(2):84-87.
- [34] 官美惠,黄艺晨,韩婷芬,等.基于肠屏障损害探讨类风湿关节炎脾虚湿毒蕴结病机的生物学基础[J].新中医,2023,55(1):13-17.
- [35] 李佳佳,任文静,尹海燕,等.应激与肠道疾病发生机制[J].世界华人消化杂志,2020,28(14):617-627.
- [36] Wang YY,Zhou YH,Wu QY,et al.Honeysuckle-derived nanovesicles regulate gut microbiota for the treatment of inflammatory bowel disease[J].Adv Sci,2025,12(45):e05208.
- [37] 李琪,孙悦,丁成华,等.肠道微生态与中医整体观探讨[J].江西中医药,2023,54(2):66-69.
- [38] Guo WQ,Ma H,Wang CZ,et al.Epigenetic studies of Chinese herbal medicine:pleiotropic role of DNA methylation[J].Front Pharmacol,2021,12:790321.
- [39] Zhou MZ,Zhang YY,Shi L,et al.Activation and modulation of the AGEs-RAGE axis:Implications for inflammatory pathologies and therapeutic interventions-A review[J].Pharmacol Res,2024,206:107282.
- [40] Guo CL,Wang YQ,Zhang SH,et al.Crataegus pinnatifida polysaccharide alleviates colitis via modulation of gut microbiota and SCFAs metabolism[J].Int J Biol Macromol,2021,181:357-368.
- [41] Shabana,Shahid SU,Irfan U,et al.Crosstalk of immunity and metabolism:interaction of toll-like receptors(TLRs)and gut microbiota[J].Acta Diabetol,2025,62(8):1183-1194.
- [42] Tong X,Chen L,He SJ,et al.Forsythia suspensa(Thunb.) Vahl extract ameliorates ulcerative colitis via inhibiting NLRP3 inflammasome activation through the TLR4/MyD88/NF-κB pathway[J].Immun Inflamm Dis,2023,11(11):e1069.
- [43] 谢诗雅,刘明巍,肖雷,等.蒲公英多酚的抑菌和抗炎活性研究[J].日用化学工业(中英文),2025,55(5):633-639.
- [44] Agirman G,Yu KB,Hsiao EY.Signaling inflammation across the gut-brain axis[J].Science,2021,374(6571):1087-1092.
- [45] 徐先涛,杨红丽,王一男.基于网络药理学和实验验证的大承气汤改善功能性便秘的作用机制研究[J].徐州医科大学学报,2025,45(4):242-248.
- [46] Xu LN,Yang QQ,Zhou JH.Mechanisms of abnormal lipid metabolism in the pathogenesis of disease[J].Int J Mol Sci,2024,25(15):8465.
- [47] 尤金彪,董金敏,张斌,等.参苓白术散对脾虚湿困证高脂血症患者的临床疗效及对肠道菌群影响[J].中国微生态学杂志,2024,36(11):1310-1317.
- [48] 伍熙雯,彭作英.中医药治疗功能性便秘的研究进展[J].中医学,2025,14(4):1497-1502.
- [49] 吴锋,祝珊珊,肖秋平,等.基于黄元御“水寒土湿木郁”理论探讨功能性便秘的诊治及其肠道微生态的改变[J].世界中西医结合杂志,2024,19(9):1839-1845,1851.
- [50] Deng M,Chen HJ,Long JY,et al.Atractylenolides(Ⅰ,Ⅱ,and Ⅲ):a review of their pharmacology and pharmacokinetics[J].Arch Pharmacal Res,2021,44(7):633-654.
- [51] 阿热爱·巴合提,武瑞赟,肖梦圆,等.益生菌的生理功能及作用机理研究进展[J].食品与发酵工业,2020,46(22):270-275.